{"DataElement":{"publicId":"2180233","version":"1","preferredName":"Laboratory Procedure Beta-2-Microglobulin Protein Outcome Specified Upper Limit of Normal Value","preferredDefinition":"the value, in mcg/ml, for the upper level of normal of the medical procedure that involves testing a sample of blood for beta-2 microglobulin, an 11-kDa protein associated with the outer membrane of many cells including lymphocytes, is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface, and is present in small amounts in serum, csf, and urine of normal people, and to a much greater degree in the urine and plasma of patients with tubular proteinemia, renal failure, or kidney transplants.","longName":"LAB_B2M_OC_SP_ULN_VA","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195483","version":"1","preferredName":"Laboratory Procedure Beta-2-Microglobulin Protein Outcome","preferredDefinition":"information related to the result of the medical procedure that involves testing a sample of blood for beta-2 microglobulin, an 11-kDa protein associated with the outer membrane of many cells including lymphocytes, is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface, and is present in small amounts in serum, csf, and urine of normal people, and to a much greater degree in the urine and plasma of patients with tubular proteinemia, renal failure, or kidney transplants.","longName":"LAB_B2MG_OC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2775192","version":"1","preferredName":"Beta-2-Microglobulin Protein Outcome","preferredDefinition":"Beta-2-microglobulin protein (119 aa, ~14 kDa) is  encoded by the human B2M gene. This protein plays a role in immune  responses and is a key component of major histocompatibility complex  class I molecules. The protein is localized to the surface of cells and  is utilized as a prognostic marker in persons with cancers that involve  white blood cells. The polypeptide is also used as a marker in kidney  damage diagnosis and in the detection of viral infection.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C62657:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Beta-2-Microglobulin","conceptCode":"C62657","definition":"Beta-2-microglobulin protein (119 aa, ~14 kDa) is encoded by the human B2M gene. This protein plays a role in immune responses and is a key component of major histocompatibility complex class I molecules. The protein is localized to the surface of cells and is utilized as a prognostic marker in persons with cancers that involve white blood cells. The polypeptide is also used as a marker in kidney damage diagnosis and in the detection of viral infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54E3DEAB-AC64-08AE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-20","modifiedBy":"ONEDATA","dateModified":"2008-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED7CBD2F-E782-2239-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2180232","version":"1","preferredName":"Beta-2 Microglobulin Specified Upper Limit of Normal Value","preferredDefinition":"the value for the upper level of normal range of a patient's beta-2 microglobulin.","longName":"B2MO_SPEC_ULN_VAL","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2500946","version":"1","preferredName":"Upper Limit of Normal Value","preferredDefinition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.:A numerical quantity measured or assigned or computed.","longName":"C25706:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Upper Limit of Normal","conceptCode":"C25706","definition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19E48A60-907F-415C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-07-31","modifiedBy":"ONEDATA","dateModified":"2006-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D1734090-EDB4-17D4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-21","modifiedBy":"CAMPBELB","dateModified":"2008-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811913","version":"1","longName":"Lymphoma","context":"CTEP"},{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"},{"publicId":"2812017","version":"1","longName":"Phase II Lung Cancer","context":"CTEP"},{"publicId":"2811832","version":"1","longName":"Lung","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811957","version":"1","longName":"Labs","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811943","version":"1","longName":"Hodgkin's Lymphoma","context":"CTEP"},{"publicId":"2811906","version":"1","longName":"Waldenstrom Macrogl","context":"CTEP"},{"publicId":"2811905","version":"1","longName":"Primary Amyloidosis","context":"CTEP"},{"publicId":"2811904","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"-COMMENT","type":"COMMENT","description":"Add instruction: mcg/ml (Note: Record institutional limits of normal)","url":null,"context":"CTEP"},{"name":"Beta-2 Microglobulin ULN","type":"Preferred Question Text","description":"Beta-2 Microglobulin ULN","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D173429D-AD5B-19CD-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-21","modifiedBy":"CAMPBELB","dateModified":"2008-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}